Matches in SemOpenAlex for { <https://semopenalex.org/work/W2600585133> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2600585133 endingPage "291" @default.
- W2600585133 startingPage "291" @default.
- W2600585133 abstract "291 Background: There are limited treatment options for patients with non-muscle invasive bladder cancer (NMIBC) who fail intravesical bacillus Calmette-Guerin (BCG). The use of light as a means of therapy for bladder cancer (BC) has a long history but has been hampered by a lack of tumor specificity and toxicity. Monoclonal antibody (mAb)-conjugates represent an emerging therapeutic approach for malignancies that improves upon tumor specificity. The use of a mAb-photo-absorber (PA) conjugate is a more selective method of delivering light therapy and has been termed “photoimmunotherapy” (PIT). In this report, PIT is used to target the epidermal growth factor receptor (EGFR). EGFR is a good tumor-specific target as it is enriched in the basal molecular subtype of BC. In the present study, anti-EGFR antibody panitumumab (pan) was labeled with the PA, IRDye 700Dx (IR700), to create a pan IR700 mAb-PA conjugate which is activated by near-infrared radiation (NIR). Methods: BC tissue microarray (TMA) and BC cell lines were analyzed for expression of EGFR. Mechanism of PIT induced cell death was studied using proliferation assays, transmission electron microscopy (TEM), and production of reactive oxygen species. Finally, the in vivo effect was studied in xenografts. Results: EGFR staining of TMAs showed that while most BCs have expression of EGFR to some degree, squamous cell carcinomas (SCC) have the highest expression of EGFR. Pan IR700 activated by NIR light rapidly killed UMUC-5 cells, a bladder SCC line. Pan alone, pan IR700 without NIR, or NIR alone had no effect on cells. TEM demonstrated that cell death is due to necrosis. Singlet oxygen species contributed towards cell death. NIR-PIT with pan IR700 reduced growth compared to only pan IR700 treated UMUC-5 xenograft tumors. Conclusions: PIT is a new targeted treatment for BC. Our data demonstrate that pan IR700-induced PIT selectively kills EGFR-expressing bladder cancer cells in vitro and in vivo and hence warrants further studies in orthotopic models and in patients. We suspect that EGFR-directed therapy with PIT is a viable strategy for the basal molecular subtype of BC and will be testing this hypothesis in the future." @default.
- W2600585133 created "2017-04-07" @default.
- W2600585133 creator A5014017269 @default.
- W2600585133 creator A5019566512 @default.
- W2600585133 creator A5038598676 @default.
- W2600585133 creator A5053327399 @default.
- W2600585133 creator A5082080836 @default.
- W2600585133 creator A5084627594 @default.
- W2600585133 creator A5090173640 @default.
- W2600585133 date "2017-02-20" @default.
- W2600585133 modified "2023-09-23" @default.
- W2600585133 title "Epidermal growth factor receptor (EGFR) targeted photoimmunotherapy (PIT) for the treatment of EGFR expressing bladder cancer." @default.
- W2600585133 doi "https://doi.org/10.1200/jco.2017.35.6_suppl.291" @default.
- W2600585133 hasPublicationYear "2017" @default.
- W2600585133 type Work @default.
- W2600585133 sameAs 2600585133 @default.
- W2600585133 citedByCount "2" @default.
- W2600585133 countsByYear W26005851332018 @default.
- W2600585133 countsByYear W26005851332023 @default.
- W2600585133 crossrefType "journal-article" @default.
- W2600585133 hasAuthorship W2600585133A5014017269 @default.
- W2600585133 hasAuthorship W2600585133A5019566512 @default.
- W2600585133 hasAuthorship W2600585133A5038598676 @default.
- W2600585133 hasAuthorship W2600585133A5053327399 @default.
- W2600585133 hasAuthorship W2600585133A5082080836 @default.
- W2600585133 hasAuthorship W2600585133A5084627594 @default.
- W2600585133 hasAuthorship W2600585133A5090173640 @default.
- W2600585133 hasBestOaLocation W26005851332 @default.
- W2600585133 hasConcept C121608353 @default.
- W2600585133 hasConcept C126322002 @default.
- W2600585133 hasConcept C142724271 @default.
- W2600585133 hasConcept C150903083 @default.
- W2600585133 hasConcept C159654299 @default.
- W2600585133 hasConcept C170493617 @default.
- W2600585133 hasConcept C203014093 @default.
- W2600585133 hasConcept C207001950 @default.
- W2600585133 hasConcept C2776362946 @default.
- W2600585133 hasConcept C2779438470 @default.
- W2600585133 hasConcept C2780352672 @default.
- W2600585133 hasConcept C502942594 @default.
- W2600585133 hasConcept C542903549 @default.
- W2600585133 hasConcept C71924100 @default.
- W2600585133 hasConcept C86803240 @default.
- W2600585133 hasConceptScore W2600585133C121608353 @default.
- W2600585133 hasConceptScore W2600585133C126322002 @default.
- W2600585133 hasConceptScore W2600585133C142724271 @default.
- W2600585133 hasConceptScore W2600585133C150903083 @default.
- W2600585133 hasConceptScore W2600585133C159654299 @default.
- W2600585133 hasConceptScore W2600585133C170493617 @default.
- W2600585133 hasConceptScore W2600585133C203014093 @default.
- W2600585133 hasConceptScore W2600585133C207001950 @default.
- W2600585133 hasConceptScore W2600585133C2776362946 @default.
- W2600585133 hasConceptScore W2600585133C2779438470 @default.
- W2600585133 hasConceptScore W2600585133C2780352672 @default.
- W2600585133 hasConceptScore W2600585133C502942594 @default.
- W2600585133 hasConceptScore W2600585133C542903549 @default.
- W2600585133 hasConceptScore W2600585133C71924100 @default.
- W2600585133 hasConceptScore W2600585133C86803240 @default.
- W2600585133 hasIssue "6_suppl" @default.
- W2600585133 hasLocation W26005851331 @default.
- W2600585133 hasLocation W26005851332 @default.
- W2600585133 hasOpenAccess W2600585133 @default.
- W2600585133 hasPrimaryLocation W26005851331 @default.
- W2600585133 hasRelatedWork W1969289591 @default.
- W2600585133 hasRelatedWork W1971628265 @default.
- W2600585133 hasRelatedWork W2046052085 @default.
- W2600585133 hasRelatedWork W2060447952 @default.
- W2600585133 hasRelatedWork W2067193714 @default.
- W2600585133 hasRelatedWork W2075195592 @default.
- W2600585133 hasRelatedWork W2089467591 @default.
- W2600585133 hasRelatedWork W2098182048 @default.
- W2600585133 hasRelatedWork W2159193724 @default.
- W2600585133 hasRelatedWork W2609459726 @default.
- W2600585133 hasVolume "35" @default.
- W2600585133 isParatext "false" @default.
- W2600585133 isRetracted "false" @default.
- W2600585133 magId "2600585133" @default.
- W2600585133 workType "article" @default.